Enhancing the user experience with new capabilities and even more scientific content
Since the Drug Interaction Database (DIDB) was acquired by Certara in June 2023, we’ve been plotting a course for the future and making investments in technology and scientific expertise to deliver the best possible user experience and most value for users of the industry’s largest scientist-curated database to assess drug interactions and safety.
See a demonstration of the newest DIDB capability, a drug-drug interaction (DDI) calculator that allows you to explore the clinical DDI risk of a compound as a precipitant (or perpetrator) based on a drug’s properties and early in vitro results.
You’ll also hear a series of updates from DIDB leaders Isabelle Ragueneau-Majilessi and Jingjing Yu on the breadth of scientific content that’s being added to the platform, consulting services now available to help users get the most out of their DIDB license, and the recent launch of Certara’s Center of Excellence (CoE) in Drug Interaction Science.
Speakers
Isabelle Ragueneau-Majlessi, MD, MS
Distinguished Scientist, Drug Interaction Solutions, Certara
Dr. Ragueneau is a Clinical Professor Emeritus from the University of Washington where she co-founded the Drug Interaction Database (DIDB) over 25 years ago. At Certara, she is the head of the Drug Interaction Solutions program and leads the Center of Excellence in Drug Interaction Science. She is a clinical pharmacologist by training, with a deep expertise in the evaluation of drug-drug interactions mechanisms and clinical significance. In 2022, she received the Gary Neil prize for innovation in drug development from the ASCPT in recognition of her extensive work with the DIDB and the impact of the tool on drug interaction research.
Jingjing Yu, MD, PhD
Director, Drug Interaction Solutions, Certara
Dr. Yu joined Certara in 2023 following the acquisition of the University of Washington Drug Interaction Solutions program. With over 15 years of experience in drug metabolism and clinical pharmacology, she brings a unique expertise in the field of drug interactions, gained through her work in both academia and industry. At Certara, Dr. Yu is Director at the Drug Interaction Solutions and a core member of Center of Excellence in Drug Interaction Science. She is also an Affiliate Associate Professor of the Department of Pharmaceutics at the University of Washington in Seattle, WA.